08:10:57 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Telescope Innovations Corp
Symbol TELI
Shares Issued 53,665,569
Close 2023-10-31 C$ 0.20
Market Cap C$ 10,733,114
Recent Sedar+ Documents

Telescope grants options to buy 357,550 shares

2023-11-01 17:52 ET - News Release

Subject: Telescope Innovations Corp. - News Release Word Document File: '\\swfile\EmailIn\20231101 144217 Attachment Tele Press Release re Stock Option Grant November 1, 2023.docx' - 2 - Telescope Announces Stock Option Grants Vancouver, BC - November 1, 2023 - Telescope Innovations Corp. ("Telescope" or the "Company") (CSE: TELI), a chemical technology company, announces that it has granted a total of 357,550 incentive stock options to certain employees and consultants of the Company in accordance with the Company's incentive stock option plan. The options vest immediately and are exercisable to acquire common shares of the Company at a price of $0.20 until November 1, 2028. About Telescope Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability. On behalf of the Board, Telescope Innovations Corp. Jason Hein, Chief Executive Officer E: jason@telescopeinn.com Forward-Looking Information Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the "Risk Factors" section of the prospectus filed by the Company and available at www.sedar.com. The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

© 2026 Canjex Publishing Ltd. All rights reserved.